Staff from HCD Economics attended EAHAD (The European Association for Haemophilia and allied disorders) 2019 in Prague recently.
Jamie O'Hara, CEO said "A great meeting this year, lots of exciting advancements and interesting questions raised.
The clinician and patient leadership shown in this community should be seen as the benchmark for all others.
HCD Economics remain highly dedicated to Haemophilia research via our novel approach to health economics and outcomes research."
